Funded Tech Companies

Ambys Medicines

Wondering who invested in Ambys Medicines? Takeda Ventures, Alexandria Venture Investments and Schroder Adveq put venture money into this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Ambys Medicines is working to fundamentally transform the lives of people suffering from severe liver diseases by creating breakthrough therapies capable of restoring liver function, preventing the progression of liver disease, and treating the devastating complications of liver failure.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/22/2021

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Jonker

        

Chief Medical Officer

Glenn Pierce

        

Chief Scientific Officer

Michael Holmes

        

Controller

Ran Xiao

        

Vice President

Stanley Hollenbach

        

VP - Bus. Development

Deidre Roniger

        

VP - Human Resources

Amanda Valentino

        

Company Investors

• Takeda Ventures (Asit Parikh)
• Alexandria Venture Investments
• Schroder Adveq
• Third Rock Ventures (Charles Homcy)
• Smilegate Investment
• Laurion Capital Management

Browse more funded tech companies:

Ambyint | AMD

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary